Exploratory Study of the Effect of IMA950/Poly-ICLC Vaccination on Response to Bevacizumab in Relapsing High-Grade Glioma Patients

DOI: 10.3390/cancers11040464

Keywords: glioma, bevacizumab, immunotherapy, IMA950, peptide vaccine

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text